Form 8-K - Current report:
SEC Accession No. 0001477932-25-002989
Filing Date
2025-04-25
Accepted
2025-04-25 17:00:20
Documents
17
Period of Report
2025-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 28388
2 EMPLOYMENT AGREEMENT upxi_101.htm EX-10.1 64657
3 EMPLOYMENT AGREEMENT upxi_102.htm EX-10.2 57131
  Complete submission text file 0001477932-25-002989.txt   309846

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA upxi-20250424.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20250424_lab.xml EX-101.LAB 15213
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20250424_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20250424_pre.xml EX-101.PRE 9640
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20250424_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 4007
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 25875046
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)